Roche Holding AG (Roche Holding AG) EV-to-Revenue

: 3.30 (As of Today)

View and export this data going back to 2002. Start your Free Trial

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Roche Holding AG's enterprise value is $225,848 Mil. Roche Holding AG's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $68,490 Mil. Therefore, Roche Holding AG's EV-to-Revenue for today is 3.30.

The historical rank and industry rank for Roche Holding AG's EV-to-Revenue or its related term are showing as below:

RHHBY' s EV-to-Revenue Range Over the Past 10 Years
Min: 3.22 Med: 4.67 Max: 5.83
Current: 3.3

During the past 13 years, the highest EV-to-Revenue of Roche Holding AG was 5.83. The lowest was 3.22. And the median was 4.67.

RHHBY's EV-to-Revenue is ranked worse than
64.75% of 1027 companies
in the Drug Manufacturers industry
Industry Median: 2.3 vs RHHBY: 3.30

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2024-04-24), Roche Holding AG's stock price is $31.24. Roche Holding AG's Revenue per Share for the trailing twelve months (TTM) ended in Dec. 2023 was $10.65. Therefore, Roche Holding AG's PS Ratio for today is 2.93.

Roche Holding AG EV-to-Revenue Historical Data

The historical data trend for Roche Holding AG's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Roche Holding AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EV-to-Revenue

Get a 7-Day Free Trial

4.48

4.63

5.20

3.84

3.63

Roche Holding AG Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EV-to-Revenue	Get a 7-Day Free Trial															5.20	-	3.84	-	3.63

Competitive Comparison

For the Drug Manufacturers - General subindustry, Roche Holding AG's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Roche Holding AG EV-to-Revenue Distribution

For the Drug Manufacturers industry and Healthcare sector, Roche Holding AG's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Roche Holding AG's EV-to-Revenue falls into.

Roche Holding AG EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Roche Holding AG's EV-to-Revenue for today is calculated as:

EV-to-Revenue	=	Enterprise Value (Today)	/	Revenue (TTM)
	=	225847.556	/	68490.408
	=	3.30

Roche Holding AG's current Enterprise Value is $225,848 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Roche Holding AG's Revenue for the trailing twelve months (TTM) ended in Dec. 2023 was $68,490 Mil.

Roche Holding AG (OTCPK:RHHBY) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Roche Holding AG's PS Ratiofor today is calculated as:

PS Ratio	=	Share Price (Today)	/	Revenue per Share (TTM)
	=	31.24	/	10.648
	=	2.93

Roche Holding AG's share price for today is $31.24.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. {COMPANY->company}'s Revenue per Sharefor the trailing twelve months (TTM) ended in Dec. 2023 was $10.65.

Roche Holding AG EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Roche Holding AG's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Roche Holding AG (Roche Holding AG) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Roche Holding AG (OTCPK:RHHBY) » Definitions » EV-to-Revenue

Comparable Companies

Traded in Other Exchanges

RHHVF:USA RHHBF:USA ROG N:Mexico ROz:UK ROGz:UK 0QOK:UK RHO6:Germany ROG:Switzerland RO:Switzerland

Address

Grenzacherstrasse 124, Basel, CHE, 4070

Website

https://www.roche.com

Roche is a Swiss biopharmaceutical and diagnostic company. The firm's best-selling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.